ArticleACS nano2026
Chiral Ligand-Protected Gold Nanoclusters as Biosensors for Small Chiral Biomolecules: A Computational Study.
Article in ACS nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Biomimetic all-metal PdScience advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Detection of chiral biomolecules in biological environments presents an important challenge: to develop sensitive, noninvasive sensors that Could have an impact in several areas such as drug discovery, diagnostics of diseases, and care. In this work, we introduce a strategy for experimentally realizable, noninvasive sensing of small chiral biomolecules in aqueous solvents, validated via classical force-field molecular dynamics simulations and density functional theory calculations. We investigated the interactions of the L/D forms of glutathione and seven chiral amino acids (Ala, Arg, Asp, Cys, Glu, Ser, Tyr) with six chiral, water-soluble, thiolate-protected gold nanoclusters in the range of 25-144 gold atoms, via dynamical sampling extending up to 3 μs time scales in water at neutral pH. We found surprisingly large variations in the binding probability (from <1% to 100%) of these analytes to the nanoclusters, with the dominating interaction being electrostatics between the analyte and the nanoclusters' ligand surface, augmented by hydrogen bonding and van der Waals interactions. Computed circular dichroism spectra for several nanocluster-analyte complexes predict the identification of analyte-specific adsorption events and even the resolution of the adsorbed enantiomer in selected cases, constituting an experimentally realizable sensing function. Our results suggest that chiral ligand-protected gold nanoclusters could be used for noninvasive chiral sensing, creating a tunable toolbox where the nanocluster size and chiral ligand type could be varied for optimizing the sensing activity for specific targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.